Another report found that PCI34051, a histone deacetylase 8 (HDAC8)-specific inhibitor, blocked SMC deacetylation and thus blocked cell cycle progression and cell survival in MCF7 breast cancer cells [36]. Here, HDAC8 is linked to breast carcinoma.